Pilot Study Comparing Technologies to Test for Substandard Drugs in Field Settings

The World Health Organization estimates that up to 200,000 of the one million deaths that occur from malaria each year could be avoided if antimalarial drugs were "effective, of good quality and used correctly" (World Health Organization, 2003). In May 2008, some of the authors published a study that found 35% of antimalarial drugs sold in private shops and pharmacies in six major African cities failed basic quality control tests (Bate et al., 2008). Additionally, tuberculosis and other bacterial infections cause millions of deaths a year; drugs to combat these diseases are also routinely counterfeited (World Health Organization, 2008).

Portable labs that perform thin-layer chromatography (TLC) provide a relatively inexpensive, versatile, and robust means of identifying substandard drugs at a fraction of the resources required for modern laboratory testing. Over 300 Global Pharma Health Fund e.V. Mini-labs (GPHF-Minilab®) are being used in 70 countries to help public authorities and private companies identify counterfeit and substandard drugs (Global Pharma Health Fund). TLC however, requires trained staff and may be time consuming.

New technologies are making it easier to test the authenticity of drugs in field settings. This paper compares two instruments that use the technologies of Raman spectrometry and near-infrared (NIR) spectrometry against TLC and disintegration testing to identify substandard drugs in the field.

Click here to view this document as an Adobe Acrobat PDF.

Roger Bate is the Legatum Fellow in Global Prosperity at AEI.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate

What's new on AEI

Obama should channel Reagan on Russia
image Tackling our nation’s budget problems, head on
image Missing the point on inversions and corporate taxes
image Venezuela betrayed — missed chance to expose regime
AEI on Facebook
Events Calendar
  • 28
    MON
  • 29
    TUE
  • 30
    WED
  • 31
    THU
  • 01
    FRI
Tuesday, July 29, 2014 | 10:00 a.m. – 12:00 p.m.
Is Medicare's future secure? The 2014 Trustees Report

Please join AEI as the chief actuary for Medicare summarizes the report’s results, followed by a panel discussion of what those spending trends are likely to mean for seniors, taxpayers, the health industry, and federal policy.

Friday, August 01, 2014 | 10:30 a.m. – 12:00 p.m.
Watergate revisited: The reforms and the reality, 40 years later

Please join us as four of Washington’s most distinguished political observers will revisit the Watergate hearings and discuss reforms that followed.

No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.